CTI BioPharma (NASDAQ:CTIC) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of CTI BioPharma (NASDAQ:CTIC – Get Rating) in a research note released on Tuesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other equities analysts have also recently commented on CTIC. Stifel Nicolaus cut shares of CTI BioPharma from a buy rating to […]

Related Keywords

United States ,Stifel Nicolaus ,Biopharma Corp ,Biopharma Company Profile ,Vanguard Group Inc ,Stonepine Capital Management ,Blackrock Inc ,Get Rating ,Street Capital ,Pharma Price ,Street Corp ,Capital Management ,Vanguard Group ,Pharma Company ,Pharma Corp ,Pharma Daily ,Cti Biopharma ,Nasdaq Ctic ,Arctic ,Medical ,Initiated Coverage ,Stocknews Com ,